Author Information
David Allan Cameron is a prominent researcher affiliated with the Edinburgh University Cancer Research Centre, IGC, Western General Hospital, Edinburgh & Breast International Group, Brussels, Belgium. His work primarily focuses on breast cancer, with significant contributions to understanding and treating hormone receptor-positive and HER2-negative breast cancer.
Research Contributions
David Allan Cameron has made substantial contributions to the field of oncology, particularly in breast cancer research. In 2022 alone, he published multiple influential papers, including studies on the effectiveness of aromatase inhibitors versus tamoxifen, serum thymidine kinase activity in metastatic breast cancer, and the impact of anti-HER2 therapy. His research often involves large-scale meta-analyses and collaborations in clinical trials, aiming to improve treatment outcomes and survival rates for breast cancer patients.
Aliases
David Allan Cameron is known by several aliases in academic publications, including David A Cameron, D. Cameron, D Cameron, D. A Cameron, David Cameron, and D.a. Cameron. Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
44,787 |
| H-index |
82 |
| Paper Count |
578 |
